Trump Executive Order Tracker

Reestablishes the Presidential Fitness Test and revitalizes the President's Council on Sports, Fitness, and Nutrition to promote youth participation in sports, improve national health, and address rising rates of obesity and inactivity. Directs federal agencies to support these initiatives and outlines strategies for nationwide engagement and fitness programming.
 
This executive order reestablishes the Presidential Fitness Test and revitalizes the President's Council on Sports, Fitness, and Nutrition to address the national health crisis and promote youth participation in sports. It directs the Secretary of Health and Human Services, in coordination with the Secretary of Education, to administer the test and support the Council's initiatives, which include developing school-based fitness programs, setting national youth fitness programs, setting goals, and launching public campaigns. The Council is also tasked with advising the President on strategies to combat childhood obesity and inactivity, enhance military readiness, and foster a culture of physical excellence across all sectors of society. 

Directs federal agencies to support the expanded use of civil commitment and institutional treatment for homeless individuals with serious mental illness or substance use disorders, while conditioning federal grants on the enforcement of anti-vagrancy laws and restricting funding for programs that permit drug use or prioritize housing without treatment. 
 
Federal agencies must promote the expanded use of civil commitment for homeless individuals with serious mental illness or substance use disorders, including by seeking the reversal of judicial precedents and termination of consent decrees that obstruct institutionalization. This order conditions federal grant funding on local enforcement of anti-vagrancy laws, such as bans on public drug use, camping, and squatting, and prohibits support for programs that emphasize housing without requiring treatment or accountability. The order also expands support for drug and mental health courts, permits more restrictive housing rules, and authorizes the collection and sharing of health data with law enforcement to enhance public safety. 

This proclamation addresses the EPA’s April 5, 2024 final rule, National Emission Standards for Hazardous Air Pollutants:  Ethylene Oxide Emissions Standards for Sterilization Facilities Residual Risk and Technology Review, 89 Fed. Reg. 24090 (EtO Rule), which imposes new emissions-control requirements on commercial sterilization facilities. The proclamation declares that that certain stationary sources subject to the EtO Rule, as identified in Annex I of the proclamation, are exempt from compliance with the EtO Rule for a period of two years beyond the EtO Rule’s relevant compliance dates. During the two-year period, the exempted stationary sources will remain subject to the emissions and compliance obligations in effect prior to the issuance of the EtO Rule.

This memorandum directs the Secretary of Health and Human Services to take appropriate action to eliminate waste, fraud, and abuse in Medicaid, including by ensuring Medicaid payments rates are not higher than Medicare.

Orders the Director of the Office of Science and Technology Policy (OSTP Director) to issue guidance for agencies on implementation of “Gold Standard Science” in the conduct and management of their respective scientific activities

This order makes it the policy of the United States to have the most-favored-nation price for prescription drugs and biologics.

This Executive Order establishes a policy of the United States to ensure that federally funded research benefits American citizens without jeopardizing national security, strength or prosperity. The order seeks to strengthen oversight of dangerous gain-of-function research on biological agents and pathogens and other high-risk life science research. It contains the following directives and deadlines.

This order makes it the policy of the United States that Federal health care programs, intellectual property protections, and safety regulations are optimized to provide access to prescription drugs at a lower cost to American patients and taxpayers. 
 
The order directs: (a) the Secretary of Health and Human Services (“Secretary”) to propose and seek comment on guidance for the Medicare Drug Price Negotiation Program within 60 days of the order; (b) the Assistant to the President for Domestic Policy, in coordination with the Secretary, the Director of the Office of Management and Budget (OMB Director), and the Assistant to the President for Economic Policy to provide recommendations to the President on how best to stabilize and reduce Medicare Part D premiums within 180 days of the order; and (c) the Secretary to work with Congress to modify the Medicare Drug Price Negotiation Program.
 
The order also contains the following directions and deadlines:

The EO announces a policy of the United States to put patients first and ensure they have the necessary information to make well-informed healthcare decisions. The order builds upon Executive Order 13877 (Improving Price and Quality Transparency in American Healthcare to Put Patients First) of June 24, 2019, and directs Secretary of the Treasury, the Secretary of Labor, and the Secretary of Health and Human Services to take all necessary and appropriate action to implement rapidly and enforce the healthcare price transparency regulations issued pursuant to that order within 90 days.